Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

We analysed antibodies specific for human p53 in sera from primary breast cancer patients using three different immunoassays and we related these results to the p53 level in tumour tissue detected by immunohistochemistry. Only 44% (11/25) of apparently enzyme-linked immunosorbent assay (ELISA)-posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vojtesek, B., Kovarik, J., Dolezalova, H., Nenutil, R., Havlis, P., Brentani, R. R., Lane, D. P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033849/
https://www.ncbi.nlm.nih.gov/pubmed/7779720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033849/
https://www.ncbi.nlm.nih.gov/pubmed/7779720

Ejemplares similares